Product information and disease descriptionPlace of product in therapyApproaches to treatment
Care management intervention strategies
11 evidence topics · 7 sources
Prophylaxis and treatment of acneiform dermatitis in the phase 1b cohort
Protocol prophylactic skin measures and suggested treatment of rash
Premedication and management of infusion-related reactions
HPV testing by primary site
“For oropharyngeal tissue specimens (i.e. non-cytology), including regional lymph nodes with metastatic SCC and clinical findings consistent with an oropharyngeal primary, pathologists should perform HR-HPV testing by surrogate marker p16 IHC.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Unlike the oropharynx, identifying HPV in primary oral cavity, laryngeal, and hypopharyngeal SCCs does not have clear and consistent implications for patient prognosis or patient management” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For oropharyngeal cancer, p16 IHC is strongly recommended” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“For recurrent and/or metastatic SCCHN, tumour PD-L1 expression should be evaluated” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote